Moatti JP - Search Results

1

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B; MANIF 2000 Study Group. Bouhnik AD, et al. Among authors: moatti jp. Antivir Ther. 2005;10(1):53-61. Antivir Ther. 2005. PMID: 15751763

2

Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south.

Moatti JP, Spire B, Kazatchkine M. Moatti JP, et al. AIDS. 2004 Jun;18 Suppl 3:S55-61. doi: 10.1097/00002030-200406003-00011. AIDS. 2004. PMID: 15322486

3

Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV care.

Rasson S, Boyer S, Fugon L, Protopopescu C, Marcellin F, Koulla-Shiro S, Kouanfack C, Spire B, Moatti JP, Carrieri MP; EVAL Study Group. Rasson S, et al. Among authors: moatti jp. Antivir Ther. 2011;16(3):423-8. doi: 10.3851/IMP1773. Antivir Ther. 2011. PMID: 21555826

4

Access to HIV prophylaxis for survivors of sexual assault: the tip of the iceberg.

Carrieri MP, Bendiane MK, Moatti JP, Rey D. Carrieri MP, et al. Among authors: moatti jp. Antivir Ther. 2006;11(3):391-2. Antivir Ther. 2006. PMID: 16759057

5

Nonadherence among HIV-infected injecting drug users: the impact of social instability.

Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, Moatti JP, Obadia Y, Spire B; MANIF 2000 Study Group. Bouhnik AD, et al. Among authors: moatti jp. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S149-53. doi: 10.1097/00126334-200212153-00013. J Acquir Immune Defic Syndr. 2002. PMID: 12562040

6

Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study.

Carrieri MP, Raffi F, Lewden C, Sobel A, Michelet C, Cailleton V, Chêne G, Leport C, Moatti JP, Spire B; APROCO study group. Carrieri MP, et al. Among authors: moatti jp. Antivir Ther. 2003 Dec;8(6):585-94. doi: 10.1177/135965350300800606. Antivir Ther. 2003. PMID: 14760892

7

Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up.

Vincent E, Bouhnik AD, Carrieri MP, Rey D, Dujardin P, Granier F, Fuzibet JG, Obadia Y, Moatti JP, Spire B; MANIF-2000 Study Group. Vincent E, et al. Among authors: moatti jp. AIDS. 2004 Jun 18;18(9):1321-5. doi: 10.1097/00002030-200406180-00011. AIDS. 2004. PMID: 15362665

8

Health related quality of life among both current and former injection drug users who are HIV-infected.

Préau M, Protopopescu C, Spire B, Sobel A, Dellamonica P, Moatti JP, Carrieri MP; MANIF-2000 Study Group. Préau M, et al. Among authors: moatti jp. Drug Alcohol Depend. 2007 Jan 12;86(2-3):175-82. doi: 10.1016/j.drugalcdep.2006.06.012. Epub 2006 Aug 22. Drug Alcohol Depend. 2007. PMID: 16930864

9

Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France.

Rey D, Bendiane MK, Bouhnik AD, Almeda J, Moatti JP, Carrieri MP. Rey D, et al. Among authors: moatti jp. AIDS Care. 2008 May;20(5):537-41. doi: 10.1080/09540120701867198. AIDS Care. 2008. PMID: 18484321

10

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP; APROCO cohort study group. Spire B, et al. Among authors: moatti jp. Soc Sci Med. 2002 May;54(10):1481-96. doi: 10.1016/s0277-9536(01)00125-3. Soc Sci Med. 2002. PMID: 12061483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters